Mark Enyedy

Insider Reports History

Location
San Diego, CA
Signature
/s/ Mark Enyedy
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Enyedy:

Company Role Class Num Shares Value Price $ Report Date Ownership
ImmunoGen, Inc. CHIEF EXECUTIVE OFFICER, Director Stock Option (Right to Buy) 0 $897,750 $4.56 12 Feb 2024 Direct
BIOMARIN PHARMACEUTICAL INC Director Common Stock 13,550 $853,379 $62.98 20 May 2025 Direct
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Director Stock Options (Right to Buy) 2,082 $281,153 $135.04 02 Jun 2025 Direct
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Director Common Stock 946 $127,747 $135.04 02 Jun 2025 Direct
ImmunoGen, Inc. CHIEF EXECUTIVE OFFICER, Director Common Stock 0 $0 $29.30 12 Feb 2024 Direct
ImmunoGen, Inc. CHIEF EXECUTIVE OFFICER, Director Restricted Stock Unit 0 $0 $29.30 12 Feb 2024 Direct
LogicBio Therapeutics, Inc. Director Common Stock 0 $2.01 16 Nov 2022 Direct
LogicBio Therapeutics, Inc. Director Stock Option (right to buy) 0 16 Nov 2022 Direct

Insider Reports Filed by Mark Enyedy

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 02 Jun 2025 2 +$408,901 4 Director 04 Jun 2025, 16:42
CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 20 May 2025 0 $0 3 Director 29 May 2025, 17:23
BMRN BIOMARIN PHARMACEUTICAL INC 20 May 2025 1 $0 4 Director 22 May 2025, 16:56
BMRN BIOMARIN PHARMACEUTICAL INC 21 May 2024 1 $0 4 Director 23 May 2024, 17:23
/report/000110465924014715-enyedy-mark-j-2024-02-12 ImmunoGen, Inc. 12 Feb 2024 8 $0 4 CHIEF EXECUTIVE OFFICER, Director 12 Feb 2024, 16:46
/report/000141588924002871-enyedy-mark-j-2024-02-02 ImmunoGen, Inc. 02 Feb 2024 3 -$588,733 4 CHIEF EXECUTIVE OFFICER, Director 06 Feb 2024, 21:42
/report/000141588924002759-enyedy-mark-j-2024-02-01 ImmunoGen, Inc. 01 Feb 2024 1 $0 4 CHIEF EXECUTIVE OFFICER, Director 05 Feb 2024, 21:23
BMRN BIOMARIN PHARMACEUTICAL INC 27 Dec 2023 1 $0 4 Director 28 Dec 2023, 13:13
BMRN BIOMARIN PHARMACEUTICAL INC 27 Dec 2023 0 $0 3 Director 28 Dec 2023, 13:11
/report/000141588923011881-enyedy-mark-j-2023-08-02 ImmunoGen, Inc. 02 Aug 2023 17 -$36,072,132 4 CHIEF EXECUTIVE OFFICER, Director 04 Aug 2023, 19:32
/report/000141588923010830-enyedy-mark-j-2023-06-30 ImmunoGen, Inc. 30 Jun 2023 1 +$21,226 4 CHIEF EXECUTIVE OFFICER, Director 05 Jul 2023, 17:57
/report/000141588923002104-enyedy-mark-j-2023-02-03 ImmunoGen, Inc. 03 Feb 2023 2 $0 4 CHIEF EXECUTIVE OFFICER, Director 07 Feb 2023, 16:20
/report/000089924322036305-enyedy-mark-j-2022-11-16 LogicBio Therapeutics, Inc. 16 Nov 2022 2 $0 4 Director 17 Nov 2022, 20:13
/report/000141588922007327-enyedy-mark-j-2022-06-30 ImmunoGen, Inc. 30 Jun 2022 1 +$12,783 4 CHIEF EXECUTIVE OFFICER, Director 05 Jul 2022, 16:28
/report/000120919122038235-enyedy-mark-j-2022-06-17 LogicBio Therapeutics, Inc. 17 Jun 2022 1 $0 4 Director 21 Jun 2022, 08:05
/report/000141588922012993-enyedy-mark-j-2022-05-20 ImmunoGen, Inc. 20 May 2022 2 $0 4 CHIEF EXECUTIVE OFFICER, Director 27 Dec 2022, 16:16
/report/000117911022000928-enyedy-mark-j-2022-02-04 ImmunoGen, Inc. 04 Feb 2022 1 +$5,852,000 4 Chief Executive Officer, Director 08 Feb 2022, 16:34
/report/000117911021007317-enyedy-mark-j-2021-06-30 ImmunoGen, Inc. 30 Jun 2021 1 +$21,246 4 Chief Executive Officer, Director 02 Jul 2021, 16:21
/report/000120919121040430-enyedy-mark-j-2021-06-11 LogicBio Therapeutics, Inc. 11 Jun 2021 1 $0 4 Director 14 Jun 2021, 20:01